You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Neprilysin Inhibition: In Heart Failure and Beyond

  • Authors: Maja Cikes, MD, PhD; John J. McMurray, MD, FRCP, FESC, FACC, FAHA, FRSE, FMedSci; Scott D. Solomon, MD
  • CPD Released: 9/29/2023
  • Valid for credit through: 9/29/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.50 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US cardiologists, primary care physicians, and nephrologists.

The goal of this activity is for learners to be better able to discuss the effect of neprilysin inhibition on the heart and beyond.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Effect of neprilysin inhibition on the heart
    • Safety of neprilysin inhibition
    • Extracardiac benefits of neprilysin inhibition


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.


Faculty

  • Maja Cikes, MD, PhD

    Associate Professor
    University of Zagreb School of Medicine
    Department of Cardiovascular Diseases
    University Hospital Center Zagreb
    Zagreb, Croatia

    Disclosures

    Maja Cikes, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca; Bayer; Boehringer Ingelheim Pharmaceuticals, Inc.; Novo Nordisk; Pulsify Medical; Roche; Swixx
    Speaker or member of speakers bureau for: Abbott; ABIOMED; Amgen, Inc.; Amicus Therapeutics, Inc.; AstraZeneca; Bayer; Boehringer Ingelheim Pharmaceuticals, Inc.; GE Healthcare; Krka Pharma; Livanova; Novartis; Novo Nordisk; Pfizer, Inc.; Pulsify Medical; Roche; Swixx; Takeda; Teva Pharmaceutical Industries Ltd.
    Research funding from: Abbott; Corvia Medical, Inc.; Novartis; Novo Nordisk; Pfizer, Inc.

  • John J. McMurray, MD, FRCP, FESC, FACC, FAHA, FRSE, FMedSci

    Professor of Medical Cardiology
    School of Cardiovascular & Metabolic Health
    BHF Glasgow Cardiovascular Research Centre
    University of Glasgow
    Glasgow, Scotland, United Kingdom

    Disclosures

    John J. McMurray, MD, FRCP, FESC, FACC, FAHA, FRSE, FMedSci, has the following relevant financial relationships:
    Consultant or advisor for: Alnylam Pharmaceuticals, Inc.; Bayer; Bristol Myers Squibb Company; George Clinical PTY Ltd.; Ionis Pharmaceuticals; Novartis; Regeneron Pharmaceuticals, Inc.; River 2 Renal Corporation
    Speaker or member of speakers bureau for: Abbott; Alkem Metabolics; AstraZeneca; Blue Ocean Scientific Solutions Ltd.; Boehringer Ingelheim Pharmaceuticals, Inc.; Emcure Pharma Ltd.; Eris Lifesciences; Hikma Pharmaceuticals; Imagica Health; Intas Pharma; J.B. Chemicals & Pharma, Ltd.; Lupin Pharmaceuticals, Inc.; ProAdWise Communications; Sun Pharmaceutical Industries, Ltd.
    Research funding from: Amgen, Inc.; AstraZeneca; Bayer; Cardurion; Cytokinetics; GlaxoSmithKline; KBP Biosciences Co., Ltd.; Novartis

  • Scott D. Solomon, MD

    Edward D. Frohlich Distinguished Chair
    Professor of Medicine
    Harvard Medical School
    Brigham and Women's Hospital
    Boston, Massachusetts, United States

    Disclosures

    Scott D. Solomon, MD, has the following relevant financial relationships:
    Consultant or advisor for: Abbott; Action Pharmaceuticals, Ltd.; Akros Pharma Inc.; Alnylam Pharmaceuticals, Inc.; American Regent; Amgen, Inc.; Anacardio; Arena Pharmaceuticals, Inc.; AstraZeneca; Bayer; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Cardiac Dimensions; Cardior; Cardurion; CellPro Thera; Corvia Medical, Inc.; Cytokinetics; Daiichi Sankyo, Inc.; Dinaqor; GlaxoSmithKline; Janssen; Lexicon Pharmaceuticals, Inc.; Lilly; Merck; Moderna, Inc.; MyoKardia; Novartis; Quantum Genomics; Roche; Sanofi Pasteur; Sarepta; Tenaya; Theracos; Tremeau Pharmaceuticals, Inc.; Valo
    Research funding from: Actelion Pharmaceuticals, Ltd.; Alnylam Pharmaceuticals, Inc.; Amgen, Inc.; AstraZeneca; Bayer; Bellerophon; Bristol Myers Squibb Company; Celladon; Cytokinetics; Eidos; Gilead Sciences, Inc.; GlaxoSmithKline; Ionis; Lilly; Mesoblast; MyoKardia; Neurotronik; Novartis; Novo Nordisk; Respicardia, Inc.; Sanofi Pasteur; Theracos; US2.AI

Editor

  • Lorena Casadonte, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Lorena Casadonte, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Neprilysin Inhibition: In Heart Failure and Beyond

Authors: Maja Cikes, MD, PhD; John J. McMurray, MD, FRCP, FESC, FACC, FAHA, FRSE, FMedSci; Scott D. Solomon, MDFaculty and Disclosures

CPD Released: 9/29/2023

Valid for credit through: 9/29/2024, 11:59 PM EST

processing....

  • Print